Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,321 | 192 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $811.38 | 25 | $0 (2024) |
| Amgen Inc. | $766.14 | 30 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $395.75 | 26 | $0 (2024) |
| Edwards Lifesciences Corporation | $360.53 | 6 | $0 (2021) |
| Abbott Laboratories | $346.96 | 7 | $0 (2024) |
| Lilly USA, LLC | $205.48 | 11 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $183.64 | 10 | $0 (2019) |
| Boston Scientific Corporation | $182.18 | 3 | $0 (2024) |
| Medtronic, Inc. | $170.98 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $168.96 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,004 | 18 | Abbott Laboratories ($222.57) |
| 2023 | $656.82 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($245.30) |
| 2022 | $126.14 | 5 | Abbott Laboratories ($60.89) |
| 2021 | $225.80 | 13 | Boehringer Ingelheim Pharmaceuticals, Inc. ($46.32) |
| 2020 | $219.66 | 7 | Amgen Inc. ($159.91) |
| 2019 | $904.02 | 38 | Amgen Inc. ($295.61) |
| 2018 | $1,324 | 55 | Edwards Lifesciences Corporation ($289.42) |
| 2017 | $860.39 | 51 | Novartis Pharmaceuticals Corporation ($151.85) |
All Payment Transactions
192 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: Cardio-renal | ||||||
| 10/07/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: VACCINE | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $138.23 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/25/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Bone Health | ||||||
| 09/10/2024 | MEDICOMP INC | TELEPATCH CARDIAC MONITOR (Device) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: CARDIOLOGY | ||||||
| 08/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/29/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $107.66 | General |
| Category: Heart Failure | ||||||
| 07/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 06/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/23/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $140.43 | General |
| Category: Coronary | ||||||
| 04/22/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/09/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $114.91 | General |
| Category: Heart Failure | ||||||
| 03/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $123.82 | General |
| Category: RESPIRATORY | ||||||
| 11/30/2023 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $122.83 | General |
| Category: Genetic Disease | ||||||
| 11/08/2023 | Medtronic, Inc. | COBALT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $170.98 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 08/22/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $120.30 | General |
| Category: DIABETES | ||||||
| 07/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 04/19/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $117.71 | General |
| Category: Cardiovascular | ||||||
| 09/26/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/22/2022 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $39.18 | General |
| Category: Cardiac Rhythm Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 203 | 212 | $134,695 | $28,714 |
| 2022 | 6 | 346 | 444 | $86,495 | $25,503 |
| 2020 | 18 | 507 | 525 | $42,540 | $7,896 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $28,560 | $7,284 | 25.5% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 27 | 27 | $30,915 | $5,907 | 19.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 33 | 33 | $31,845 | $5,814 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 25 | $11,250 | $2,954 | 26.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 13 | 13 | $13,585 | $2,397 | 17.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 22 | $6,050 | $1,590 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 16 | $5,120 | $1,341 | 26.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 11 | $4,565 | $1,195 | 26.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 17 | $2,805 | $231.64 | 8.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 125 | $25,000 | $10,485 | 41.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 47 | 48 | $38,400 | $9,173 | 23.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 40 | 62 | $12,400 | $3,380 | 27.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 101 | 139 | $9,035 | $1,903 | 21.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $1,070 | $388.19 | 36.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 52 | 59 | $590.00 | $173.55 | 29.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 39 | 44 | $6,600 | $1,281 | 19.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 19 | $3,800 | $1,068 | 28.1% |
| 82306 | Vitamin d-3 level | Office | 2020 | 28 | 28 | $2,100 | $812.28 | 38.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 40 | 48 | $3,120 | $482.27 | 15.5% |
| 84481 | Thyroid hormone, t3 measurement | Office | 2020 | 29 | 29 | $2,175 | $481.40 | 22.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2020 | 29 | 29 | $2,175 | $477.34 | 21.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2020 | 29 | 29 | $2,175 | $428.62 | 19.7% |
| 82746 | Folic acid level | Office | 2020 | 29 | 29 | $2,175 | $417.89 | 19.2% |
| 82728 | Ferritin (blood protein) level | Office | 2020 | 29 | 29 | $2,175 | $387.44 | 17.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 29 | 29 | $2,175 | $380.48 | 17.5% |
About Dr. Robert Struhl, M.D
Dr. Robert Struhl, M.D is a Cardiovascular Disease healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306814975.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Struhl, M.D has received a total of $5,321 in payments from pharmaceutical and medical device companies, with $1,004 received in 2024. These payments were reported across 192 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,321).
As a Medicare-enrolled provider, Struhl has provided services to 1,056 Medicare beneficiaries, totaling 1,181 services with total Medicare billing of $62,112. Data is available for 3 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Great Neck, NY
- Active Since 03/09/2006
- Last Updated 09/20/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1306814975
Products in Payments
- JARDIANCE (Drug) $807.82
- Repatha (Biological) $448.23
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $334.35
- ENTRESTO (Drug) $318.79
- CARDIOMEMS (Device) $222.57
- Corlanor (Drug) $203.72
- COBALT DR MRI SURESCAN (Device) $170.98
- Belviq (Drug) $162.83
- WATCHMAN FLX (Device) $146.56
- FFRct (Device) $140.43
- FARXIGA (Drug) $139.26
- INVOKANA (Drug) $136.12
- AREXVY (Drug) $123.82
- AMVUTTRA (Drug) $122.83
- CAMZYOS (Drug) $117.71
- PRALUENT ALIROCUMAB INJECTION (Biological) $104.71
- TRADJENTA (Drug) $101.59
- JANUVIA (Drug) $91.68
- TOUJEO (Drug) $86.78
- HUMULIN (Drug) $82.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Great Neck
Dr. Evan Schwarzwald, D.o, D.O
Cardiovascular Disease — Payments: $449,880
Dr. Steven Goldberg, M.d, M.D
Cardiovascular Disease — Payments: $78,555
Dr. David Stern, M.d, M.D
Cardiovascular Disease — Payments: $25,959
Dr. Lauren Boglioli, Md Facc Facp Fccp, MD FACC FACP FCCP
Cardiovascular Disease — Payments: $15,130
Dr. Joel Goldberg, Md, MD
Cardiovascular Disease — Payments: $8,960
Navid Ahmed, M.d, M.D
Cardiovascular Disease — Payments: $8,200